Acuren Corporation Cancellation of Listing

RNS Number : 6768A

Acuren Corporation

16 August 2024

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

​

For immediate release

​

Acuren Corporation (formerly known as Admiral Acquisition Limited)

​

CANCELLATION OF LISTING ON THE OFFICIAL LIST AND TRADING ON THE LONDON STOCK EXCHANGE

​

16 August 2024 - Acuren Corporation (formerly known as Admiral Acquisition Limited) (LSE: ADMR / ADMW) (the "Company") announces that further to its announcement of 30 July 2024, the Company confirms that it expects the cancellation of the listing of its ordinary shares and warrants from the Official List of the Financial Conduct Authority and the cancellation of the admission to trading of its ordinary shares and warrants from the Main Market of the London Stock Exchange will take effect from 8:00 a.m. (London time) on Monday, 19 August 2024.

​

About Acuren

Acuren is a leading North American provider of critical asset integrity services. Acuren provides mission critical, regulatorily-mandated, nondestructive testing, inspection and engineering & lab testing services across a variety of industrial end markets. Acuren operates across three service lines: Nondestructive Testing ("NDT"), Rope Access Technician solutions ("RAT") and Engineering and Lab Testing. NDT offerings include breadth of nondestructive testing services including conventional, advanced and tech-enabled NDT.  RAT offerings include a full suite of rope access technician offerings including inspection, repair and specialty craft services.  Engineering and Lab Testing offerings include materials engineering and lab testing services.  

​

Enquiries:

Ed Hammond

[e-mail]

[phone]

 

Dan Moore

[e-mail]

[phone]

Legal Entity Identifier (LEI): 213800ZDFRNC8QXEZ481

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCQKPBNDBKBNFD